Skip to content
TrialScanner

NCT03888612

Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer

Phase 1/Phase 2CompletedARVNLead

Registry record

Lead sponsor
Arvinas Inc.
Conditions
Prostate Cancer Metastatic
Primary completion
Apr 29, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03888612 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03888612: Trial of ARV-110 in Patients... | TrialScanner